Skip to search formSkip to main contentSkip to account menu

M-VAC protocol

Known as: M-VAC regimen, MVAC protocol, CDDP/DOX/MTX/VBL 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (3)

Antineoplastic Combined Chemotherapy ProtocolsMethotrexateVinblastine
CisplatinDoxorubicinDoxorubicin HydrochlorideMVAC Regimen

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Full-ZVS modulation for all-SiC ISOP-type isolated front end (IFE) solid-state transformer
Thanks to their comparatively low system complexity, SSTs based on an isolated front end (IFE) approach are suitable for space… 
2015
2015
Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification.
2014
2014
Final results of EORTC intergroup randomized phase III trial comparing immediate versus deferred chemotherapy after radical cystectomy in patients with pT3T4 and/or N+ M0 transitional cell carcinoma…
4500 Background: Patients (pts) with muscle invasive TCC of the bladder have poor overall survival (OS) due to systemic disease… 
Review
2012
Review
2012
Recent Advances in Treatment of Advanced Urothelial Carcinoma
GC (cisplatin and gemcitabine) and MVAC (methotrexate, vinblastine, Adriamycin [doxorubicin], and cisplatin) have been the… 
2011
2011
Prospective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin [MVAC] versus gemcitabine/cisplatin) in patients with…
4510 Background: The combinations of methotrexate, vinblastine, doxorubicin hydrochloride (Adriamycin), cisplatin (MVAC) and… 
2010
2010
MVDC connection of offshore wind farms to the transmission system
This paper describes an innovative Medium Voltage Direct Current electrical grid system (MVDC) for wind farms, based on… 
Review
2009
Review
2009
Systemic Therapy of Advanced Urothelial Cancer
Opinion statementAdvanced bladder/urothelial cancer remains an incurable terminal disease, and accounts for 3% of the cancer… 
2004
2004
The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan
BackgroundWe conducted a multiinstitutional analysis to clarify the clinical significance of perioperative chemotherapy, in… 
2000
2000
MVAC-therapy for advanced urothelial carcinoma in an anuric renal transplant recipient.
1995
1995
Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.
A phase II combination chemotherapy protocol combining methotrexate, vinblastine, doxorubicin, and cisplatin was designed to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)